+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

p53 overexpression in normal and dysplastic tissues adjacent to p53 negative squamous cell carcinomas of the head and neck



p53 overexpression in normal and dysplastic tissues adjacent to p53 negative squamous cell carcinomas of the head and neck



International Journal of Oncology 11(1): 97-104



p53 overexpression was present in the normal or dysplastic epithelium, but absent in the adjacent invasive cancers of five patients with head and neck squamous cell carcinomas (HNSCC), when p53 immunostaining (IHC) was performed. In three of the five p53 immunoreactive dysplasias and adjacent p53 negative invasive cancers single stranded conformation polymorphism (SSCP) results from exon 7 and 8 were also obtained. Bandshifts in exon 7 were detected in two dysplasias, and bandshifts in exon 8 were found in a third. Sequencing of exon 7 in the first dysplasia with bandshift indicated a deletion of codon 241-242 (loss of CT) resulting in a frame shift. In the second dysplasia with bandshift a mutation was observed in codon 244 resulting in a Gly fwdarw Arg substitution in the protein sequence. In the adjacent IHC p53 negative invasive cancer lesions, no bandshifts could be observed by SSCP, and sequencing did not reveal any mutated p53. WAF1/p21 (IHC) expression was assayed to study p53 function. Image cytometry (ICM) DNA analysis, estimating genetic instability, showed progress in DNA aberration for invasive cancer lesions as compared with the dysplasias. Human papillomavirus (HPV DNA) was not detected by a polymerase chain reaction (PCR) in any of the five cancers thus excluding possible p53 degradation caused by HPV protein. In conclusion, the finding of p53 mutations in mild, moderate, and severe dysplasia indicates that p53 mutation, not only p53 immunoreactivity, can be an early event in HNSCC carcinogenesis. The lack of p53 immunoreactivity in the invasive cancers adjacent to p53 positive dysplasias could possibly be attributed to loss of the mutant allele, or clonal heterogeneity.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 009150530

Download citation: RISBibTeXText

PMID: 21528185

DOI: 10.3892/ijo.11.1.97


Related references

MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues. Oral Diseases 6(6): 376-382, 2000

Exression of multidrug resistance (Mdr1) gene in human normal tissues and head and neck squamous cell carcinomas (Hnscc). Anti-Cancer Drugs 5: 12, 1994

Overexpression of Pim-1 in head and neck squamous cell carcinomas. International Journal of Oncology 30(6): 1381-1387, 2007

Overexpression of cyclin D1 in head and neck squamous cell carcinomas. Proceedings of the American Association for Cancer Research Annual Meeting 37: 208, 1996

Prognostic value of S-phase fraction in head and neck squamous cell carcinomas and nodal negative breast carcinomas. Strahlentherapie und Onkologie 170(1): 13-24, 1994

The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa. European Journal of Cancer. Part B Oral Oncology 30b(2): 138-141, 1994

Management of clinically negative neck for the patients with head and neck squamous cell carcinomas in the modern era. Oral Oncology 44(9): 817-822, 2008

Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. British Journal of Cancer 59(4): 559-562, 1989

CENP-F gene amplification and overexpression in head and neck squamous cell carcinomas. Head & Neck 23(2): 104-112, 2001

FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy. RadioTherapy and Oncology 122(3): 437-444, 2017

Overexpression of a novel lysyl oxidase-like gene in human head and neck squamous cell carcinomas. Anticancer Research 23(3b): 2585-2591, 2003

Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target (Review). Oncology Reports 41(5): 2615-2624, 2019

Overexpression and amplification of glutathione S-transferase pi gene in head and neck squamous cell carcinomas. Clinical Cancer Research 3(1): 111-114, 1997

Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations. Diagnostic Molecular Pathology 3(2): 83-92, 1994

Overexpression of TWIST2 correlates with poor prognosis in head and neck squamous cell carcinomas. Oncotarget 2(12): 1165-1175, 2011